The results of the GSEA showed that the P53, focal adhesion, and NOD-like receptor signaling pathways were the primary enriched pathways in the high-risk group of patients with NSCLC (adjusted p-value <0.05, Figure 7). The gene discussed is TP53; the disease is non-small cell lung carcinoma.